| Trial Identifier: | D3250C00093 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Not applicable
|
| NCTID:: | NCT05384938 |
| Start Date: | November 2021 |
| Primary Completion Date: | July 2023 |
| Study Completion Date: | July 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Hindi Translation | |
| Marathi Translation | |
| Telugu Translation | |
| Bengali Translation | |
| Urdu Translation | |
| Kannada Translation | |
| Tamil Translation |
| Country | Location |
|---|---|
| IN | Bengaluru, IN, 560099 |
| IN | Chennai, IN, 600035 |
| IN | Delhi, IN, 110029 |
| IN | Hyderabad, IN, 500084 |
| IN | Jaipur, IN, 302039 |
| IN | Jodhpur, IN, 342005 |
| IN | Luknow, IN, 226003 |
| IN | Mumbai, IN, 400008 |
| IN | New Delhi, IN, 110060 |
| IN | Noida, IN, 201 301 |
| IN | Noida, IN, 201304 |
| IN | Noida, IN, 201301 |
| IN | Vishakhapatnam, IN, 530002 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company